DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations AS Rifaioglu, E Nalbat, V Atalay, MJ Martin, R Cetin-Atalay, T Doğan Chemical science 11 (9), 2531-2557, 2020 | 166 | 2020 |
Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents B Çalışkan, E Sinoplu, K İbiş, E Akhan Güzelcan, R Çetin Atalay, ... Journal of enzyme inhibition and medicinal chemistry 33 (1), 1352-1361, 2018 | 38 | 2018 |
Treatment of breast cancer with autophagy inhibitory microRNAs carried by AGO2-conjugated nanoparticles O Unal, Y Akkoc, M Kocak, E Nalbat, AI Dogan-Ekici, H Yagci Acar, ... Journal of nanobiotechnology 18, 1-18, 2020 | 36 | 2020 |
CROssBAR: comprehensive resource of biomedical relations with knowledge graph representations T Doğan, H Atas, V Joshi, A Atakan, AS Rifaioglu, E Nalbat, A Nightingale, ... Nucleic acids research 49 (16), e96-e96, 2021 | 24 | 2021 |
Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells K İbiş, E Nalbat, B Çalışkan, DC Kahraman, R Cetin-Atalay, E Banoglu European Journal of Medicinal Chemistry 221, 113489, 2021 | 17 | 2021 |
DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations. Chem Sci 11: 2531–2557 AS Rifaioglu, E Nalbat, V Atalay, MJ Martin, R Cetin-Atalay, T Dogan | 5 | 2020 |
CROssBAR: comprehensive resource of biomedical relations with deep learning applications and knowledge graph representations T Doğan, H Atas, V Joshi, A Atakan, AS Rifaioglu, E Nalbat, A Nightingale, ... bioRxiv, 2020.09. 14.296889, 2020 | 3 | 2020 |
EXPLOITING MOLECULAR NETWORKS BY REPURPOSED DRUGS AND NOVEL SMALL MOLECULES IN HEPATOCELLULAR CARCINOMA CELLS AND STEM CELLS FOR NEW THERAPEUTIC OPTIONS E NALBAT Middle East Technical University, 2023 | | 2023 |
Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity S Turanlı, E Nalbat, D Lengerli, K Ibis, S Güntekin Ergün, ... ACS omega 7 (41), 36206-36226, 2022 | | 2022 |
Network-based in silico modeling for drug repurposing and in vitro validation in hepatocellular carcinoma E Nalbat, N Tunçbağ, R Cetin-Atalay 15th International Symposium on Health Informatics and Bioinformatics HIBIT …, 2022 | | 2022 |
Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools R Cetin-Atalay, DC Kahraman, E Nalbat, AS Rifaioglu, A Atakan, ... Journal of Gastrointestinal Cancer 52 (4), 1266-1276, 2021 | | 2021 |
In vitro validation of drug-target interactions revealed in silico by Comprehensive Resource of Biomedical Relations with Network Representations and Deep … E Nalbat, AS Rifaioglu, T Dogan, MJ Martin, R Cetin-Atalay, V Atalay Cancer Research 80 (16_Supplement), 5235-5235, 2020 | | 2020 |
In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma E Sinoplu, N Tuncbag, DC Kahraman, RC Atalay Cancer Research 79 (13_Supplement), 996-996, 2019 | | 2019 |
Development of spion-based theranostic nanocarriers for small rna delivery and cancer gene therapy E Sinoplu | | 2016 |
Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma E Nalbat, E Akhan Güzelcan, S Turanlı, D Lengerli, B Çalışkan, E Banoğlu, ... | | |
Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma E Nalbat, N Tunçbağ, R Atalay | | |
Bazı Visinal Diaril Heterosiklik Bileşiklerin Antikanser Aktivitelerinin Araştırılması S Turanli, E Nalbat, E Akhan Güzelcan, R Atalay, B Çalışkan, E Banoğlu | | |
Novel isoxazole-piperazine derivatives inhibit the stemness of HCC cells E NALBAT, K İBİŞ, B ÇALIŞKAN, E BANOĞLU, M ATALAY, R ATALAY | | |
KARACİĞER KANSERİ KÖK HÜCRELERİ ÜZERİNDE İNHİBİTÖR ETKİYE SAHİP, POTANSİYEL ANTİKANSER AJANLAR OLARAK YENİ İZOKSAZOL-PİPERAZİN HİBRİTLERİNİN SENTEZİ VE BİYOLOJİK OLARAK … K İbiş, E Nalbat, B Çalışkan, R Atalay, E Banoğlu | | |
Synthesis of New Vicinal Diaryl Five-Membered Heterocyclic Compounds with Potential Anticancer Activity S TURANLİ, D LENGERLİ, B ÇALIŞKAN, ECE AKHAN GÜZELCAN, ... | | |